its about the royalties...these 'known' payments would be milestone payments. Royalties are an unknown. They have royalties starting for Rituximab starting next year, and then they would see the royalties from the deal with spectrum in 3 years. We don't know what this is - say spectrum sees 5% of the total sale?? Assume sales 'increase' in value by 2014 - it could be a 10 billion market by then, 5% of that is 500 million...even if it were 10% royalties, that is 50m annually for them. Just for this 1 deal. Obviously this is a crude example and I could be way off, but this is the kind of speculation that makes this real interesting, plus the fact that you see what, 1 pink sheet company a year ever mentioned on a nasdaq company PR???
Market Data 
Markets 
AI
